Journals / Eurasian Journal of Medicine / 2013 / Cilt: 45 - Sayı: 1

Metoclopramide-Induced Acute Dystonic Reaction: A Case Report

Pages
58–59
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Metoclopramide can cause severe adverseevents, such as an acute dystonic reaction, and should be used withcaution in patients with infectious diseases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this case report is to draw attention to the frequent occur- rence of metoclopramide-induced movement disorders.
📊
Key Findings & Data:We report acase of an acute dystonic reaction to metoclopramide in a patienttreated for hepatitis A.
💡
Conclusion & Impact:Metoclopramide can cause severe adverseevents, such as an acute dystonic reaction, and should be used withcaution in patients with infectious diseases.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The aim of this case report is to draw attention to the frequent occur- rence of metoclopramide-induced movement disorders. We report acase of an acute dystonic reaction to metoclopramide in a patienttreated for hepatitis A. Metoclopramide can cause severe adverseevents, such as an acute dystonic reaction, and should be used withcaution in patients with infectious diseases.

Özet

Bu olgu sunumunun amacı metoklopramidin indüklediği hareketbozukluklarına dikkat çekmektir. Hepatit A nedeniyle tedavi edilen hastada metoklopramid kullanımına bağlı gelişen akut distonik reaksiyon olgusu sunulmaktadır. Metoklopramid akut distonik reaksiyon gibi ciddi yan etkilere sebep olduğundan infeksiyon hastalıklarınındestek tedavisinde dikkatle kullanılmalıdır.

🔖

Cite This Article

KADANALİ, A., ANADOL, U., YUCEL, M., DEDE, B., BEKTASOGLU, M. F., KARAGOZ, G. (2022). Metoclopramide-Induced Acute Dystonic Reaction: A Case Report. Eurasian Journal of Medicine, Cilt: 45 - Sayı: 1, 58–59. https://ajindex.com/articles/509441

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Miller LG, Jankovic J. Metoclopramide-induced movement dis- orders. Clinical findings with a review of the literature. Arch Intern Med 1989; 149: 2486-92
  2. Rang, HP, Dale MM, Ritter JM, et al. Pharmacology (5th ed.). Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4, 2003 3. Guala A, Mittino D, Ghini T, Quazza G. Are metoclopramide dys- tonias familial? Pediatr Med Chir 1992; 14: 617-8
  3. Geyer HL, Bressman SB. The diagnosis of dystonia. Lancet Neurol 2006; 5: 780-90
  4. Bressman SB. Dystonia genotypes, phenotypes, and classifica- tion. Adv Neurol 2004; 94: 101-7
  5. Herrstedt J. Development of antiemetic therapy in cancer patients. Acta Oncol 1995; 34: 637-40
  6. Albibi R, McCallum RW. Metoclopramide: pharmacology and clinical application. Ann Intern Med 1983; 98: 86-95
  7. DiPalma JR. Metoclopramide: a dopamine receptor antagonist. Am Fam Physician 1990; 41: 919-24
  8. Halac G, Ergunes M, Kocael P. Metoclopramide induced acute dystonic reaction: a case report. Parkinson Hast Hareket Boz Der 2009; 12: 35-8.